Government proposes to bring 354 medicines under control list to bring down the prices of essential drugs, Chemicals and Fertilisers Minister Ramvilas Paswan told the Lok Sabha today.
Replying to supplementaries during Question Hour, he said the government has asked state-run hospitals to use generic drugs for treatment of patients in a bid to make healthcare more accessible to the poor.
Paswan said the government has launched health insurance scheme for BPL families under which free medicines of upto Rs 35,000 would be made available for treatment.
He said a Group of Ministers is deliberating the draft National Pharmaceutical Policy which has provisions for strengthening of the drug regulatory system and the patent office infrastructure, focus on research and development, human resource development in pharma sciences, rationalisation of excise duty on pharmaceuticals and streamlining system of bulk procurement of drugs by the government.
"The final decision on the issue of Pharmaceutical Policy can only be taken after the GoM takes a decision in this regard. The finalisation of the policy is therefore delayed," Paswan said. Requisite information on clarifications sought by the GoM have already been furnished.
The Department is constantly making efforts for expediting the decision of the GoM for early finalisation of the Pharma Policy, he said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
